Low-density-lipoprotein apheresis

Lancet. 1995 Jul 8;346(8967):116; author reply 117.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Anticholesteremic Agents / administration & dosage
  • Anticholesteremic Agents / therapeutic use*
  • Blood Component Removal*
  • Cholestyramine Resin / administration & dosage
  • Cholestyramine Resin / therapeutic use
  • Colestipol / administration & dosage
  • Colestipol / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / drug therapy
  • Hyperlipoproteinemia Type II / therapy*
  • Lipoproteins, LDL / blood*
  • Lovastatin / administration & dosage
  • Lovastatin / analogs & derivatives*
  • Lovastatin / therapeutic use
  • Simvastatin

Substances

  • Anticholesteremic Agents
  • Lipoproteins, LDL
  • Cholestyramine Resin
  • Lovastatin
  • Simvastatin
  • Colestipol